Antoniucci Diana M, Yamashita Takeyoshi, Portale Anthony A
University of California-San Francisco, 533 Parnassus Avenue, San Francisco, CA 94143-0748, USA.
J Clin Endocrinol Metab. 2006 Aug;91(8):3144-9. doi: 10.1210/jc.2006-0021. Epub 2006 May 30.
Fibroblast growth factor 23 (FGF-23) is important in the regulation of phosphorus and vitamin D metabolism. States of excess circulating FGF-23 are associated with renal phosphate wasting and inappropriately low serum 1,25-dihydroxyvitamin D [1,25(OH)(2)D] concentrations. Conversely, states of absent or biologically inactive circulating FGF-23 are associated with increased serum phosphorus and 1,25(OH)(2)D concentrations. Restriction of the dietary intake of phosphorus increases renal phosphate reabsorption and 1,25(OH)(2)D production, whereas the opposite occurs when dietary phosphorus is supplemented.
We sought to determine whether serum FGF-23 concentration is regulated by dietary phosphorus and thereby mediates the physiological response of serum 1,25(OH)(2)D to changes in dietary phosphorus.
DESIGN, SETTING, AND PARTICIPANTS: We studied 13 healthy men as inpatients during a 4-wk dietary phosphorus intervention study.
Subjects consumed a constant diet that provided 500 mg of phosphorus per day, which was supplemented to achieve three phosphorus intakes, each of 9 d: 1) control = 1500 mg/d; 2) supplemented = 2300 mg/d; 3) restricted = 625 mg/d. Intakes of calcium, sodium, potassium, magnesium, and energy were constant.
Serum FGF-23, 1,25(OH)(2)D, phosphorus, and calcium concentrations were measured.
Serum FGF-23 concentrations decreased significantly from 30.7 +/- 8.7 pg/ml during phosphorus supplementation to 19.6 +/- 7.0 pg/ml during phosphorus restriction. Serum 1,25(OH)(2)D concentrations increased significantly from 29 +/- 10 pg/ml (75 +/- 26 pmol/liter) during phosphorus supplementation to 40 +/- 16 pg/ml (104 +/- 42 pmol/liter) during phosphorus restriction (P < 0.001). Serum 1,25(OH)(2)D concentrations varied inversely with those of serum FGF-23 (r = -0.67, P < 0.001).
We conclude that in healthy men, changes in dietary phosphorus within the physiological range of intakes regulate serum FGF-23 concentrations and suggest that dietary phosphorus regulation of 1,25(OH)(2)D production is mediated, at least in part, by changes in circulating FGF-23.
成纤维细胞生长因子23(FGF - 23)在磷和维生素D代谢的调节中起重要作用。循环中FGF - 23过多的状态与肾性磷酸盐消耗以及血清1,25 - 二羟基维生素D [1,25(OH)(2)D]浓度异常降低有关。相反,循环中FGF - 23缺乏或无生物学活性的状态与血清磷和1,25(OH)(2)D浓度升高有关。限制饮食中磷的摄入量可增加肾磷酸盐重吸收和1,25(OH)(2)D的产生,而补充饮食中的磷时则会出现相反的情况。
我们试图确定血清FGF - 23浓度是否受饮食中磷的调节,从而介导血清1,25(OH)(2)D对饮食中磷变化的生理反应。
设计、地点和参与者:在一项为期4周的饮食磷干预研究中,我们将13名健康男性作为住院患者进行研究。
受试者食用一种固定饮食,每天提供500毫克磷,并通过补充使其达到三种磷摄入量,每种摄入量持续9天:1)对照组 = 1500毫克/天;2)补充组 = 2300毫克/天;3)限制组 = 625毫克/天。钙、钠、钾、镁和能量的摄入量保持恒定。
测量血清FGF - 23、1,25(OH)(2)D、磷和钙的浓度。
血清FGF - 23浓度从磷补充期间的30.7±8.7皮克/毫升显著下降至磷限制期间的19.6±7.0皮克/毫升。血清1,25(OH)(2)D浓度从磷补充期间的29±10皮克/毫升(75±26皮摩尔/升)显著增加至磷限制期间的40±16皮克/毫升(104±42皮摩尔/升)(P < 0.001)。血清1,25(OH)(2)D浓度与血清FGF - 23浓度呈负相关(r = -0.67,P < 0.001)。
我们得出结论,在健康男性中,生理摄入范围内饮食中磷的变化调节血清FGF - 23浓度,并表明饮食中磷对1,25(OH)(2)D产生的调节至少部分是由循环中FGF - 23的变化介导的。